Publications
17
Citations
402
Est. group size
~3
Recurring co-author estimate
Active years
11
Publishing since 2016
This publication record appears to span two distinct research areas: cancer biology (particularly glioma and DNA repair mechanisms, including work on how tumor cells respond to chemotherapy drugs like temozolomide and ATR inhibitors) and cognitive neuroscience (studying the cerebellum's role in social cognition in schizophrenia). Because these topics differ so substantially, it's possible the bibliographic record reflects contributions to multiple projects or collaborations rather than a single continuous research program. Prospective students should verify directly with the researcher which specific area and ongoing projects they would be joining.
Publication output has been irregular over the past decade, with a cluster of activity in 2018-2019 (cancer biology), a gap in 2020-2022, and renewed but modest output from 2023 onward shifting toward neuroscience topics.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Cerebellum-Cerebrum Dynamics During Gaze Processing in Schizophrenia: Evidence for Social-Cognitive Modulation and Associations with Social Functioning Across Independent Samples
Biological Psychiatry Cognitive Neuroscience and Neuroimaging · 2026
- Contributions of the posterior cerebellum to mentalizing and social functioning: A transdiagnostic investigation
Psychological Medicine · 2025
- 37. Aberrant Cerebellar-Cortical Connectivity Contributes to Social Cognitive Deficits in Schizophrenia
Biological Psychiatry · 2025
- Contributions of the Posterior Cerebellum to Mentalizing and Social Functioning: A Transdiagnostic Investigation
2024
- Supplementary Data from Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
2023
- Data from Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
2023
- Supplementary Data from Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
2023
- Data from Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
2023
- Verteporfin treatment controls morphology, phenotype, and global gene expression for cells of the human nucleus pulposus
JOR Spine · 2020
- Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
Cancer Research · 2019
- PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma
Nature Communications · 2019
- MGMT-Deficiency Is a Biomarker to Guide Treatment of Solid Tumors with Temozolomide and ATR Inhibitors
International Journal of Radiation Oncology*Biology*Physics · 2019
- Temozolomide-Resistant Glioma Cells Are Sensitive to Chloroethylating Nitrosourea Compounds in Combination with ATR Inhibitors
International Journal of Radiation Oncology*Biology*Physics · 2019
- EXTH-55. TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS
Neuro-Oncology · 2019
- Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair
Nature Genetics · 2018
- International Journal of Radiation Oncology*Biology*Physics×2
- Neuro-Oncology×2
- Nature Genetics×1
- Cancer Research×1
- Nature Communications×1
- Pedro C. Silberman
Medicine · The Ohio State University
- Monica Venere
Medicine · The Ohio State University
- Aline Paixão Becker
Medicine · The Ohio State University
- Arnab Chakravarti
Medicine · The Ohio State University
- Sara Khan
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile